Using network pharmacology approaches to identify treatment mechanisms for codonopsis in esophageal cancer

Area of Science:

• Pharmacology
• Computational Biology
• Oncology

Background:

• Esophageal cancer presents a significant global health challenge.
• Traditional medicine, including Codonopsis, offers potential therapeutic avenues.
• Network pharmacology provides a systems-level approach to understanding drug mechanisms.

Purpose of the Study:

• To elucidate the therapeutic mechanisms of Codonopsis for esophageal cancer using network pharmacology.
• To identify key compounds, targets, and pathways involved in Codonopsis-based esophageal cancer treatment.

Main Methods:

• Gathered Codonopsis compounds and targets from the Laboratory of Systems Pharmacology.
• Identified esophageal cancer targets and screened potential Codonopsis targets using GeneCards.
• Constructed protein-protein interaction networks and performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.

Main Results:

• Screened 21 Codonopsis compounds and identified 31 drug-disease intersecting targets.
• GO enrichment analysis revealed numerous biological processes, cellular components, and molecular functions.
• KEGG analysis identified 90 signaling pathways, highlighting the significance of p53 and PI3K-Akt signaling pathways.

Conclusions:

• Codonopsis exhibits potential for treating esophageal cancer through a multi-component, multi-target, and multi-pathway approach.
• The identified pathways provide a basis for further experimental validation and drug development.
• Network pharmacology is a valuable tool for exploring the complex mechanisms of traditional medicines.